• 不 限
  • 期刊论文
  • 硕博论文
  • 会议论文
  • 报 纸
  • 英文论文
  2. 您的位置
  3. 首页
  4. 会议论文
  5. Macroeconomic Aspects Of Hematopoietic Stem Cell Transplantation And Potential Implications

Macroeconomic Aspects Of Hematopoietic Stem Cell Transplantation And Potential Implications

来源 :The 35th World Congress of the International Society of Hema | 被引量 : 0次 | 上传用户：malsway
【摘 要】
：
Background Transplantation of cells,tissues,and organs has been recognized by the World Health Organization (WHO) as an important medical task for its member states.
【作 者】
：
Michael Gratwoh Marcelo Pasquini Mahmoud Aljurf Helen Baldomero Minako Iida Louis Fernando Bouzas Denis Confer Lydia Foeken Yoshiko Atsuta Hildegard Greinix Nicolas Novitzky Jeff Szer Louis Nu(n)ez Ka 
【机 构】
：
University of St. Gallen(HSG);Worldwide Network of Blood and Marrow Transplantation WBMT
【出 处】
：
The 35th World Congress of the International Society of Hema
【发表日期】
：
2014年5期
下载到本地 , 更方便阅读
下载此文 赞助VIP
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Background Transplantation of cells,tissues,and organs has been recognized by the World Health Organization (WHO) as an important medical task for its member states.
其他文献
High incidence of c-MYC abnormality in mantle cell lymphoma with bone marrow involvement and predict
Introduction The clinical characteristics and cytogenetic aberrations of mantle celll ymphoma (MCL) is well described in the West,but not in China,especially not mentioned the patients with bone marro
会议
Genome-wide DNA methylation analysis reveals activation of Wnt signaling pathway in peripheral T-cel
Background:Peripheral T-cell lymphoma-not otherwise specified (PTCL-NOS)constitutes a heterogeneous group of T-cell malignancy.Resistant to conventional chemotherapy,patients usually have poor disease
会议
Risk factor of Central nervous system for patients with diffuse large B-cell lymphoma in post-Ritxim
Background Central nervous system (CNS) relapse would seriously impair the prognosis of the patients with diffuse large B-cell lymphoma (DLBCL).However the risk factors of CNS relapse remain unclear,e
会议
Identification of Epigenetic Regulator MMSET as a Biomarker in the Pathogenesis of Lymphoma
Purpose MMSET (WHSC1/NSD2) is a SET domain-containing histone H3K36 methyltransferase.Its expression is deregulated in a subgroup of multiple myelomas (MM) with the t(4;14)(p16;q32)translocation assoc
会议
Clinical Study of Dose-adjusted EPOCH Regimen for Non-Hodgkin's Lymphoma with Hemophagocytic Ly
Introduction Hemophagocytic lymphohistiocytosis (HLH),also known as hemophagocytic syndrome (HPS) is characterized by cytokines storm and uncontrolled activation of macrophages.Secondary HLH in adults
会议
The Influence of Decreased Levels of High Density Lipoprotein Cholesterol on Hematological Indices i
Background Changes in lipoproteins levels in sickle cell disease (SCD) patients are well-known,but the physiological ramifications of the low levels observed have not been entirely resolved.Aim The ai
会议
The role of minor paroxysmal nocturnal hemoglobinuria clones in response to immunosuppressive therap
Objective Whether paroxysmal nocturnal hemoglobinuria clones in aplastic anemia is a prognostic factor to immunosuppressive therapy is a subject of debate.The aim of this study was to evaluate the hem
会议
Multicenters Egyptian Experience Of Autologous Stem Cell Transplantation In Non Hodgkin Lymphoma Com
Background The Non-Hodgkin lymphomas (NHL) comprise a heterogeneous group of malignancies.NHL includes both B-cell and T-cell malignancies.High dose chemotherapy followed by autologous stem cell trans
会议
Mobilising peripheral hematopoietic stem cell using biosimilar granulocyte colony stimulating factor
Introduction Mobilisation of hematopoietic peripheral blood stem cell (PBSC) represent a standard procedure in patients prior to an autologous stem cell transplant.Starting 2008,the biosimilars GCSF w
会议
Oral versus Intravenous Fludarabine as part of a reduced-Intensity conditioning for allogeneic stem
Introduction Oral fludarabine was introduced in the United States in 2003 for the treatment of patients with hematologic malignancies as an alternative to its intravenous(i.v.) formulation,introduced
会议